Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > June 30 short interest
View:
Post by sunshine7 on Jul 12, 2016 4:29pm

June 30 short interest

on Nasdaq down marginally to 11,968,532 shares, essentially unchanged. Days to cover, however, increased to 30 days due to lower trade volume (much of which is wash trading to manage the price. Should there ever be a catalyst bringing more buyers on board, there will be explosive upside.
Comment by puma1 on Jul 12, 2016 4:39pm
Sorry, but given no details required and hence no mechanism to monitor jigging the system, I cannot accept that 35% plus of the open float has been shorted on the thinnest exchange. It does not make sense and u could be short CXRX and long CXR and just report to the US that u r short CXRX. There is just a smell test problem here imo.
Comment by regardless on Jul 12, 2016 5:10pm
ok puma ..fair enough..but how would you explain the innability of the stock to advance ??? even when the markets were on a tear today...we lost money.....seems like the short numbers are in fact correct...and you know danmn well that they can cover in less than 30 trading days...because some scumbag will just start a rumour and publish it...and when the price runs up, theyll kill it and everyone ...more  
Comment by puma1 on Jul 12, 2016 5:34pm
easy regardless, the generic non-r&d sector are all trading about 3 to 5 times cash flows and so is CXR. No one else in the sector is screaming and we are in that group. The market is discounting all guidance in the sector by 50% or so. It is a show me market and without any catalysts, we sit and wait and don't bother for a while. The current multiples are well below trends and will ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse